The Infectious Disease (ID) Research Program is dedicated to discovering better ways to diagnose, treat and prevent infectious diseases. Comprised of clinical investigators, research associates, nurses, microbiologists and laboratory technicians, our research program has had a considerable impact on the practice of clinical medicine, including changes in national and international policy and recommendations on the treatment and prevention of diseases in children.
Clinical Trials Within ID
At any given time, there could be 25 to 50 studies underway within ID ranging from small projects enrolling one to two patients with special needs to large studies involving thousands of subjects. Examples include:
- Studies defining the epidemiology of infectious disease pathogens
- Interventional trials of new antibiotics, antivirals or antifungals aimed at treating viruses, bacteria or fungi
- Molecular studies of pathogen transmission and spread within diverse settings, including the hospital, transplant units, daycare and communities - both in the United States and in developing countries
- Investigations determining the dosing and safety of new antiretroviral medications for HIV-infected children and interventions to improve the long-term health of HIV-infected children and adolescents
You Can Make a Difference: Take Part in a Clinical Trial
Infectious diseases are the most common cause of morbidity and mortality in children and many of them are either preventable via vaccines or treatable with anti-infectives. Clinical research and trials focused on infectious diseases are essential to improving the health of children locally and globally. To take part in a clinical trial, please contact one of our research staff members, Amanda Adler or Kirsten Lacombe, MSN.
Help us answer questions about childhood health and illness, and help other children in the future. Learn more.